AAVS Opposes Pet Cloning
An overwhelming 80 percent of the public has stated its opposition to cloning companion animals such as cats and dogs, yet companies still try on occasion to make a business out of selling cloned pets and "banking" tissues from beloved pets for future cloning. Pet cloning has been promoted as a way to "bring back" or "copy" a beloved companion animal. However, attempts to clone pets represent little more than exaggerated claims and false promises.
Studies show that cloning remains an experimental technology with an extremely high failure rate. Behind each cute picture of a cuddly cloned cat or dog lie hundreds of animals who were kept in laboratory cages and subjected to painful and invasive procedures to produce just that one cloned animal. For all that, you end up with a cloned animal who is unlikely to resemble the original physically or behaviorally and may experience serious health problems. Meanwhile, millions of animals languish in shelters awaiting adoption every year.
With our No Pet Cloning campaign, AAVS seeks to protect both animals and people from harm and exploitation. We vigorously campaigned until the only U.S. companies that sold cloned animals closed their doors. First it was Genetic Savings & Clone, Inc, and then it was BioArts International. Currently, cat and dog cloning experiments for commercial pet sales are only being conducted in South Korea.
When BioArts closed, its owner, Lou Hawthorne, finally admitted to the problems with pet cloning that we have been warning about for years. According to Hawthorne, he has seen numerous abnormalities during his pet cloning attempts:
"One clone � which was supposed to be black and white � was born greenish-yellow where it should have been white. Others have had skeletal malformations, generally not crippling though sometimes serious and always worrisome. One clone of a male donor was actually born female (we still have no good explanation for how that happened)."
Hawthorne spent years trying to clone his family dog, Missy, as part of his venture. Yet, according to an article on the Veterinary Information Network, Inc., "Hawthorne's mother, who was the original owner of Missy, says the clones have very different temperaments from the original. For one thing, the original Missy was 'robust and completely calm.' But the clones are 'delicate and aggressive,' she said. In fact, she does not even own any of the clones. In the time it took to reproduce Missy, she got another 'real' dog, she said."
Revived attempts to turn cloning into a commercial business are little more than money-making schemes designed to take advantage of pet lovers at the expense of animals. AAVS will continue to take the lead in protecting animals from the threats of pet cloning and educating the public about the truth behind pet cloning.
We invite you to support our efforts and explore our website to learn more about the animal welfare problems, ethical concerns, deception, and lack of regulation associated with pet cloning.
AAVS Responds to Expansion of Dog Cloning in South Korea, 01/15/10.
The American Anti-Vivisection Society (AAVS) condemns the recent news that, through a court-ordered settlement, South Korean company RNL Bio Co, Ltd has amassed exclusive rights to clone dogs
Read More »
"US Company Drops Commercial Cloning" The Korea Times, 09/11/09.
A U.S. bio-tech company that had been involved in commercial dog cloning said it will discontinue the business after the failure of legal efforts to prevent its South Korean rival from offering cloning services.
Read More »